Skip to main
TMDX

TMDX Stock Forecast & Price Target

TMDX Analyst Ratings

Based on 10 analyst ratings
Buy
Strong Buy 40%
Buy 30%
Hold 30%
Sell 0%
Strong Sell 0%

Bulls say

TransMedics Group is experiencing market share loss and pricing pressure from potential competition in the organ transplant therapy market, as well as slowing growth in their OCS share and overall US end market growth. However, the potential upside from new partnerships, initiatives, and financials from their ENHANCE PART B and DENOVO programs may help improve investor sentiment and drive stock price rebound.

Bears say

TransMedics Group is facing challenges in its sales growth and market penetration, which may lead to a slowdown in revenue growth in the near future. Despite its innovative technology and multiple FDA approvals, the company's margins have decreased due to investments in future growth, potentially limiting earnings upside. Additionally, competition in the market may pose a risk to the company's current market share.

TMDX has been analyzed by 10 analysts, with a consensus rating of Buy. 40% of analysts recommend a Strong Buy, 30% recommend Buy, 30% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Transmedics Group Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Transmedics Group Inc (TMDX) Forecast

Analysts have given TMDX a Buy based on their latest research and market trends.

According to 10 analysts, TMDX has a Buy consensus rating as of Jun 26, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $130.80, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $130.80, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Transmedics Group Inc (TMDX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.